|Day Low/High||104.22 / 107.66|
|52 Wk Low/High||79.20 / 121.98|
Jim Cramer offers his views on how to hang on in scary markets.
As part of Care Innovations ® focus on expanding into adjacent markets, the company is proud to announce its exclusive global partnership with PRA Health Sciences (NASDAQ:PRAH).
The healthcare team led by James Momtazee has been very busy, with deals for PharMerica, American Medical Response and Covenant Surgical Partners, among others.
The most recent short interest data has been released for the 04/28/2017 settlement date, which shows a 380,230 share decrease in total short interest for PRA Health Sciences Inc , to 1,186,518, a decrease of 24.27% since 04/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
The midcap drug maker is finding growth as an outsourcing destination.
Private equity firms' publicly traded equity holdings are a valuable source of ideas for growth and value investors, alike.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.